The Oxford clinic’s core team comprises three neurology consultants, a nurse consultant, a specialist nurse and occupational therapist. We work closely with respiratory and gastroenterology colleagues. There are ~250 individuals living with MND and related disorders in active follow-up, with 130 new patient referrals annually. In addition to participating in clinical trials, we run a number of research programs. Professor Talbot leads on the cellular biology including the development of rodent models and stem cell-derived motor neuron culture systems. Professor Turner leads a large biomarker program combining multimodal neuroimaging with biofluid sampling. Dr Thompson is focused on biofluid protein characterization, including pre-symptomatic cohorts through our Families for the Treatment of Hereditary MND (FaTHoM) initiative. We organise MND training courses for allied healthcare professionals.
LocationJohn Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, United Kingdom
Completed
Phase iii
Industry trial
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).